INS and type 1 diabetes mellitus: Even more interesting is that CGM sensors enabled the realization of the artificial pancreas (AP), i.e., a device designed mainly for Type 1 diabetes (T1D), which is aimed at maintaining the BG concentration within the safety range by automatically injecting insulin via an insulin pump controlled by a closed-loop control algorithm [22,23,24,25].